LeIF A en es it fr

LeIF A Brand names, LeIF A Analogs

LeIF A Brand Names Mixture

  • No information avaliable

LeIF A Chemical_Formula

C860H1353N227O255S9

LeIF A RX_link

No information avaliable

LeIF A fda sheet

LeIF A msds (material safety sheet)

LeIF A Synthesis Reference

No information avaliable

LeIF A Molecular Weight

19241.1

LeIF A Melting Point

No information avaliable

LeIF A H2O Solubility

No information avaliable

LeIF A State

Liquid

LeIF A LogP

-0.336

LeIF A Dosage Forms

No information avaliable

LeIF A Indication

For the treatment of oral warts arising from HIV infection

LeIF A Pharmacology

Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R.

LeIF A Absorption

No information avaliable

LeIF A side effects and Toxicity

No information avaliable

LeIF A Patient Information

No information avaliable

LeIF A Organisms Affected

Humans and other mammals